Serum Institute of India chief executive officer Adar Poonawalla. File. | Photo Credit: Kamal Narang Serum Institute of India’s Chief Executive Officer Adar Poonawalla has said their Covovax vaccine will get approval as a booster against COVID-19 in the next 10 to 15 days. The vaccine works very well against the Omicron variant of coronavirus, … Read more
Serum Institute CEO Adar Poonawalla on Wednesday Tweeted “vaccine hesitancy is now the greatest threat in overcoming this pandemic”. This comes on a day when the health ministry report mentioned India has administered over 114 crore vaccines. Serum Institute CEO Adar Poonawalla tweeted that the vaccine industry has worked tirelessly to provide enough stocks for … Read more
The diagnostic solution will be jointly introduced in the international markets including the United States, Europe and Asia.” Biotechnology firm Mylab Discovery Solutions has entered into a partnership with US-based medical diagnostic device company called Hemex Health to develop portable diagnostic solutions for the Point-of-Care (POC) testing of the novel coronavirus and other diseases. The … Read more
In the first week of April, Poonawalla had sought Rs 3,000 crore from the government to scale up production from 70 million doses a month to 100 million doses a month by June-July. Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday thanked Prime Minister Narendra Modi and Finance Minister N Sitharaman for the … Read more
Serum Institute of India (SII) is reportedly readying one billion doses of five different coronavirus vaccines — Covishield, Covovax, COVIVAXX, COVI-VAC, and SII COVAX — worldwide before the end of 2021-22. CEO Adar Poonawalla said beginning with ‘Covishield’ coronavirus vaccine, Serum plans to launch at least one vaccine every quarter likely by 2021 beginning. Covishield, … Read more